CIK 0000784199 · Large accelerated filer
ARTIVION, INC.
Sign in to watch- Ticker
- AORT
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 592417093
- Phone
- 7704193355
- Business address
- 1655 ROBERTS BOULEVARD N W, KENNESAW, GA, 30144
- Former names
- CRYOLIFE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,529,843
- in 3 filings
Net −$2,529,843. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-02 | Holloway Jean F SVP, General Counsel | Sale | −2,183 | $38.02 | $83K | 170,105 |
| 2026-03-02 | Berry Lance A EVP, COO, CFO & Treasurer | Sale | −5,178 | $38.02 | $197K | 176,269 |
| 2026-03-02 | Davis John E Chief Commercial Officer | Sale | −2,784 | $38.02 | $106K | 206,522 |
| 2026-02-24 | Horton Amy VP, Chief Accounting Officer | Sale | −830 | $35.69 | $30K | 127,497 |
| 2026-02-24 | Horton Amy VP, Chief Accounting Officer | Grant or award | +5,658 | 133,155 | ||
| 2026-02-24 | Stanton Marshall S. SVP, Clinical & MD Affair | Sale | −1,259 | $35.69 | $45K | 41,921 |
| 2026-02-24 | Holloway Jean F SVP, General Counsel | Sale | −1,668 | $35.69 | $60K | 152,203 |
| 2026-02-24 | Holloway Jean F SVP, General Counsel | Grant or award | +20,085 | 172,288 | ||
| 2026-02-24 | Mackin James P President & CEO | Sale | −13,936 | $35.69 | $497K | 766,095 |
| 2026-02-24 | Mackin James P President & CEO | Grant or award | +97,030 | 863,125 | ||
| 2026-02-24 | Berry Lance A EVP, COO, CFO & Treasurer | Sale | −4,485 | $35.69 | $160K | 143,965 |
| 2026-02-24 | Berry Lance A EVP, COO, CFO & Treasurer | Grant or award | +37,482 | 181,447 | ||
| 2026-02-24 | Davis John E Chief Commercial Officer | Sale | −2,075 | $35.69 | $74K | 188,868 |
| 2026-02-24 | Davis John E Chief Commercial Officer | Grant or award | +20,438 | 209,306 | ||
| 2026-02-23 | Horton Amy VP, Chief Accounting Officer | Sale | −1,731 | $37.59 | $65K | 128,327 |
| 2026-02-23 | Stanton Marshall S. SVP, Clinical & MD Affair | Sale | −2,423 | $37.59 | $91K | 43,180 |
| 2026-02-23 | Holloway Jean F SVP, General Counsel | Sale | −3,079 | $37.59 | $116K | 153,871 |
| 2026-02-23 | Mackin James P President & CEO | Sale | −20,962 | $37.59 | $788K | 780,031 |
| 2026-02-23 | Berry Lance A EVP, COO, CFO & Treasurer | Sale | −4,981 | $37.59 | $187K | 148,450 |
| 2026-02-23 | Davis John E Chief Commercial Officer | Sale | −3,773 | $37.59 | $142K | 190,943 |
Page 3 of 11 · 201 trades